Related Experiment Videos
[Overactive bladder: prospects and limitations of botulinum toxin]
D Scheiner1, D Perucchini, D Fink
1Klinik für Gynäkologie, Departement Frauenheilkunde, Universitätsspital Zürich, Zürich, Schweiz. david.scheiner@usz.ch
Gynakologisch-Geburtshilfliche Rundschau
|June 17, 2006
Summary
Botulinum toxin injections effectively treat overactive bladder by blocking nerve signals to the detrusor muscle. This minimally invasive procedure offers significant symptom reduction for many patients.
Area of Science:
- Neuroscience
- Toxicology
- Urology
Context:
- Overactive bladder (OAB) significantly impacts quality of life.
- Current treatments for OAB have limitations.
- Botulinum toxin is a potent neurotoxin produced by Clostridium botulinum.
Purpose:
- To evaluate the efficacy and safety of intravesical botulinum toxin injections for treating detrusor overactivity.
- To understand the mechanism of action of botulinum toxin in the lower urinary tract.
Summary:
- Botulinum toxin's heavy chain facilitates cellular entry, while the light chain cleaves essential nerve terminal proteins.
- This action prevents acetylcholine release, leading to chemodenervation of the detrusor muscle.
- Intravesical injection of botulinum toxin reduces OAB symptoms by inhibiting detrusor muscle activity.
Impact:
- Clinical studies report 60-96% success rates for neurogenic and non-neurogenic detrusor overactivity.
- Botulinum toxin offers an efficient, safe, and minimally invasive treatment option for OAB.
- This approach provides significant symptom relief for patients with refractory overactive bladder.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...